APA (7th ed.) Citation

D, A., J, W., M, P., JL, B., IM, C., A, D., . . . L, O. (2025). Five-Year Results With Patisiran for Hereditary Transthyretin Amyloidosis With Polyneuropathy: A Randomized Clinical Trial With Open-Label Extension. JAMA neurology, 82(3), 228. https://doi.org/10.1001/jamaneurol.2024.4631

Chicago Style (17th ed.) Citation

D, Adams, et al. "Five-Year Results With Patisiran for Hereditary Transthyretin Amyloidosis With Polyneuropathy: A Randomized Clinical Trial With Open-Label Extension." JAMA Neurology 82, no. 3 (2025): 228. https://doi.org/10.1001/jamaneurol.2024.4631.

MLA (9th ed.) Citation

D, Adams, et al. "Five-Year Results With Patisiran for Hereditary Transthyretin Amyloidosis With Polyneuropathy: A Randomized Clinical Trial With Open-Label Extension." JAMA Neurology, vol. 82, no. 3, 2025, p. 228, https://doi.org/10.1001/jamaneurol.2024.4631.